CEBD Coronavirus Dermatology Resource
Journal articles - Coronavirus aetiology, severity and transmission
[Selected articles of dermatological relevance]
Extraordinary claims without extraordinary evidence controversy on anti-androgen therapy for COVID-19.
Trüeb RM, Régnier A, Caballero-Uribe N, Dias MFRG, Dutra Rezende H.
J Eur Acad Dermatol Venereol. 2021 Mar 30. doi: 10.1111/jdv.17249. Online ahead of print. Commentary.
Chitin-lipid interactions and the potential relationship between Demodex and SARS-CoV-2.
Tatu AL, Nadasdy T, Nwabudike LC.
Dermatol Ther. 2021 Mar 9:e14935. doi: 10.1111/dth.14935. Online ahead of print. Review / commentary.
The overlap between genetic susceptibility to COVID-19 and skin diseases.
Jabalameli N, Rajabi F, Firooz A, Rezaei N.
Immunol Invest. 2021 Jan 26:1-8. doi: 10.1080/08820139.2021.1876086. Online ahead of print. Commentary.
Inflammation and vascular injury as the basis of COVID-19 skin changes: Preliminary analysis of 23 patients from the literature.
Zheng Y, Gong Z, Chen J, Lin Y, Liu Y.
Clin Cosmet Investig Dermatol. 2021 Jan 6;14:1-7. doi: 10.2147/CCID.S278833. eCollection 2021. Review & data analysis.
COVID-19-associated cutaneous manifestations: does HHV-6 play an etiological role?
Abadías-Granado I, Navarro-Bielsa A, Morales-Callaghan AM, Roc L, Suso-Estívalez CC, Povar-Echeverría M, Gilaberte Y.
Br J Dermatol. 2021 Jan 8. doi: 10.1111/bjd.19806. Online ahead of print. Cross-sectional study / case-control study.
Spectrum of clinicopathologic findings in COVID-19-induced skin lesions: Demonstration of direct viral infection of the endothelial cells.
Garrido Ruiz MC, Santos-Briz Á, Santos-Briz Á, Sánchez A, Alonso-Riaño M, Burgos J, Medina-Miguelañez M, Puebla L, Román-Curto C, Roncero-Riesco M, Garcia R, Ortiz PL, Rodriguez-Peralto JL.
Am J Surg Pathol. 2021 Jan 4;Publish Ahead of Print. doi: 10.1097/PAS.0000000000001634. Online ahead of print. Case series / pathology study.
SARS-CoV-2 not found in pressure injury exudates from COVID-19 patients.
Yu N, Zhang Y, Xiao M, Cao W, Zhang Y, Yang Y, Liu Z, Li Y, Long X, Liu Z, Zhang S, Wang X.
J Cosmet Dermatol. 2020 Dec 21. doi: 10.1111/jocd.13887. Online ahead of print. Case series.
Could injured skin be a reservoir for SARS-CoV-2 virus spread?
Elgarhy LH, Salem ML.
Clin Dermatol. 2020 Nov-Dec;38(6):762-763. doi: 10.1016/j.clindermatol.2020.06.004. Epub 2020 Jun 9. Commentary.
Gene expression of angiotensin-converting enzyme 2 receptor in skin and the implications for COVID-19.
Al-Benna S.
Adv Skin Wound Care. 2021 Jan;34(1):31-35. doi: 10.1097/01.ASW.0000722748.73437.7d. Genetic database analysis.
Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster.
Goren A, Cadegiani FA, Wambier CG, Vano-Galvan S, Tosti A, Shapiro J, Mesinkovska NA, Ramos PM, Sinclair R, Lupi O, Hercogova J, McCoy J.
Med Hypotheses. 2020 Nov 28:110439. doi: 10.1016/j.mehy.2020.110439. Online ahead of print. Commentary.
Response to Tembhre et al.: 'Enhanced expression of ACE2 in psoriatic skin and its upregulation in keratinocytes by interferon-gamma: Implication of inflammatory milieu in skin tropism of SARS-CoV-2'.
Gehlhausen JR, Ko CJ, Damsky W.
Br J Dermatol. 2020 Dec 10. doi: 10.1111/bjd.19714. Online ahead of print. Commentary.
Delayed hypersensitivity as a pathophysiological mechanism in cutaneous lesions due to SARS-CoV-2.
Rafai M, Elbenaye J, Sabry S, Janah H.
Pan Afr Med J. 2020 Jul 16;35(Suppl 2):115. doi: 10.11604/pamj.supp.2020.35.2.24980. eCollection 2020. Case report.
Impaired type I interferon response in SARS-CoV-2 infection: looking through the cutaneous window.
Bessis D.
Br J Dermatol. 2020 Nov 29. doi: 10.1111/bjd.19596. Online ahead of print. Commentary.
From dermatological conditions to COVID-19: reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy.
Criado PR, Miot HA, Pincelli TPH, Fabro AT.
Dermatol Ther. 2020 Nov 20. doi: 10.1111/dth.14565. Online ahead of print. Review / commentary.
Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention.
Kasperkiewicz M.
Cell Stress Chaperones. 2020 Nov 16. doi: 10.1007/s12192-020-01180-3. Online ahead of print. Commentary.
If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19.
Xu Q, Chen L, Li X, Zheng J.
J Am Acad Dermatol. 2020 Nov 4:S0190-9622(20)32905-4. doi: 10.1016/j.jaad.2020.10.084. Online ahead of print. Case series & pathology study.
Dermatological aspects of SARS-CoV-2 infection: mechanisms and manifestations.
Garduño-Soto M, Choreño-Parra JA, Cazarin-Barrientos J.
Arch Dermatol Res. 2020 Nov 6. doi: 10.1007/s00403-020-02156-0. Online ahead of print. Review.
Enhanced expression of ACE2 in psoriatic skin and its upregulation in keratinocytes by interferon-gamma: Implication of inflammatory milieu in skin tropism of SARS-CoV-2.
Tembhre MK, Parihar AS, Sharma VK, Imran S, Bhari N, Lakshmy R, Bhalla A.
Br J Dermatol. 2020 Nov 6. doi: 10.1111/bjd.19670. Online ahead of print. Case-control & pathology study.
5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia.
McCoy J, Cadegiani FA, Wambier CG, Herrera S, Vaño-Galván S, Mesinkovska NA, Ramos PM, Shapiro J, Sinclair R, Tosti A, Goren A.
J Eur Acad Dermatol Venereol. 2020 Nov 2. doi: 10.1111/jdv.17021. Online ahead of print. Retrospective cohort study.
COVID-19: Topical agents and therapeutic prevention of nasal viral acquisition.
Abdelhadi S, Ruszczak Z, Schwartz RA.
Dermatol Ther. 2020 Oct 26. doi: 10.1111/dth.14454. Online ahead of print. Review / commentary.
Alopecia and gray hair are associated with COVID-19 severity.
Ramos PM, Ianhez M, Miot HA.
Exp Dermatol. 2020 Oct 24. doi: 10.1111/exd.14220. Online ahead of print. Survey / cross-sectional study.
CD147 as a novel receptor in the pathogenesis of SARS-CoV-2: Is there any correlation with risk of COVID-19 in dermatological diseases?
Pourani MR, Abdollahimajd F.
Dermatol Ther. 2020 Oct 22:e14443. doi: 10.1111/dth.14443. Online ahead of print. Review / commentary.
ACE2 expression on the keratinocytes and SARS-CoV-2 percutaneous transmission, are they related?
Zhu R, Shi Y, Tan Y, Xiao R.
J Invest Dermatol. 2020 Oct 14:S0022-202X(20)32172-2. doi: 10.1016/j.jid.2020.09.019. Online ahead of print. Commentary.
New data about sexually transmitted COVID19.
Tatu AL, Nadasdy T, Nwabudike LC.
Dermatol Ther. 2020 Oct 19:e14426. doi: 10.1111/dth.14426. Online ahead of print. Commentary.
Sexually transmitted diseases in the COVID-19 era.
Wiggins CJ, Rosen T.
Skinmed. 2020 Aug 1;18(4):210-212. eCollection 2020. Review.
Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis.
Krueger JG, Murrell DF, Garcet S, Navrazhina K, Lee PC, Muscianisi E, Blauvelt A.
J Allergy Clin Immunol. 2020 Sep 28:S0091-6749(20)31332-4. doi: 10.1016/j.jaci.2020.09.021. Online ahead of print. Research study.
Teachings from COVID-19 and aging - an oxidative process.
Zarbafian M, Dayan S, Fabi SG.
J Cosmet Dermatol. 2020 Sep 30. doi: 10.1111/jocd.13751. Online ahead of print. Review / commentary.
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men.
Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R.
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16953. Online ahead of print. Prospective cohort study.
Androgen receptor genetic variant predicts COVID-19 disease severity: A prospective longitudinal study of hospitalized COVID-19 male patients.
McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A.
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16956. Online ahead of print. Prospective cohort study.
Shedding light on the myths of ultraviolet radiation in the Covid-19 pandemic.
O'Connor C, Courtney C, Murphy M.
Clin Exp Dermatol. 2020 Sep 24. doi: 10.1111/ced.14456. Online ahead of print. Review / commentary.
Male balding as a major risk factor for severe COVID-19: a possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals.
Wambier CG, McCoy J, Goren A.
J Am Acad Dermatol. 2020 Sep 11:S0190-9622(20)32600-1. doi: 10.1016/j.jaad.2020.09.015. Online ahead of print. Commentary.
Harnessing cooperative immune augmentation by contact allergens to enhance the efficacy of viral vaccines.
Cunningham LS, McFadden JP, Basketter DA, Ferguson FJ, White IR, Kimber I.
Contact Dermatitis. 2020 Aug 9. doi: 10.1111/cod.13685. Online ahead of print. Review / commentary.
COVID‐19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen.
Schön MP, Berking C, Biedermann T, Buhl T, Erpenbeck L, Eyerich K, Eyerich S, Ghoreschi K, Goebeler M, Ludwig RJ, Schäkel K, Schilling B, Schlapbach C, Stary G, von Stebut E, Steinbrink K.
J Dtsch Dermatol Ges. 2020 Aug;18(8):795-809. doi: 10.1111/ddg.14169_g. Review. German.
Skin manifestations in COVID-19 provide a clue for disease's pathophysiology understanding.
Kubanov AA, Deryabin DG.
J Eur Acad Dermatol Venereol. 2020 Sep 1. doi: 10.1111/jdv.16902. Online ahead of print. Review / commentary.
Potential interactions of SARS-CoV-2 with human cell receptors in the skin: understanding the enigma for a lower frequency of skin lesions compared to other tissues.
Criado PR, Pincelli TPH, Criado RFJ, Abdalla BMZ, Belda Junior W.
Exp Dermatol. 2020 Aug 31. doi: 10.1111/exd.14186. Online ahead of print. Review.
Coronavirus disease of 2019 (COVID-19) facts and figures: What every dermatologist should know at this hour of need.
Manchanda Y, Das S, De A.
Indian J Dermatol. 2020 Jul-Aug;65(4):251-258. doi: 10.4103/ijd.IJD_360_20. Review.
The rise and evolution of COVID-19.
Baghchechi M, Jaipaul N, Jacob SE.
Int J Womens Dermatol. 2020 Jun 26. doi: 10.1016/j.ijwd.2020.06.006. Online ahead of print. Review.
Pathologic features of COVID-19: A concise review.
Tabary M, Khanmohammadi S, Araghi F, Dadkhahfar S, Tavangar SM.
Pathol Res Pract. 2020 Sep;216(9):153097. doi: 10.1016/j.prp.2020.153097. Epub 2020 Jul 4. Review.
COVID-19 and Vitamin D: A lesson from the skin.
Slominski RM, Stefan J, Athar M, Holick MF, Jetten AM, Raman C, Slominski AT.
Exp Dermatol. 2020 Aug 11. doi: 10.1111/exd.14170. Online ahead of print. Commentary / hypothesis.
Androgen sensitivity in COVID-19 and antiandrogens: prospective data are still needed.
Ianhez M, Ramos PM, Goren A, Miot HA.
Dermatol Ther. 2020 Aug 9:e14166. doi: 10.1111/dth.14166. Online ahead of print. Survey / cross-sectional study.
COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.
Schön MP, Berking C, Biedermann T, Buhl T, Erpenbeck L, Eyerich K, Eyerich S, Ghoreschi K, Goebeler M, Ludwig RJ, Schäkel K, Schilling B, Schlapbach C, Stary G, von Stebut E, Steinbrink K.
J Dtsch Dermatol Ges. 2020 Aug 6. doi: 10.1111/ddg.14169. Online ahead of print. Review.
Organ-specific manifestations of COVID-19 infection.
Gavriatopoulou M, Korompoki E, Fotiou D, Ntanasis-Stathopoulos I, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA.
Clin Exp Med. 2020 Jul 27. doi: 10.1007/s10238-020-00648-x. Online ahead of print. Review.
Male balding is a major risk factor for severe COVID-19.
Lee J, Yousaf A, Fang W, Kolodney M.
J Am Acad Dermatol. 2020 Jul 21:S0190-9622(20)32262-3. doi: 10.1016/j.jaad.2020.07.062. Online ahead of print. Cross-sectional study.
SARS-CoV-2, COVID-19, skin and immunology - what do we know so far?
Novak N, Peng WM, Naegeli MC, Galvan C, Kolm-Djamei I, Brüggen MC, Cabanillas B, Schmid-Grendelmeier P, Catala A.
Allergy. 2020 Jul 13. doi: 10.1111/all.14498. [Epub ahead of print]. Review.
Lessons from dermatology about inflammatory responses in Covid-19.
Criado PR, Pagliari C, Carneiro FRO, Quaresma JAS.
Rev Med Virol. 2020 Jul 12:e2130. doi: 10.1002/rmv.2130. [Epub ahead of print]. Review.
Sexually transmitted COVID19.
Abdelmaksoud A, Vestita M, Goldust M.
Dermatol Ther. 2020 Jul 8. doi: 10.1111/dth.13982. [Epub ahead of print] No abstract available. Commentary.
Immunology of COVID-19: mechanisms, clinical outcome, diagnostics and perspectives - a report of the European Academy of Allergy and Clinical Immunology (EAACI).
Sokolowska M, Lukasik Z, Agache I, Akdis CA, Akdis D, Akdis M, Barcik W, Brough H, Eiwegger T, Eliaszewicz A, Eyerich S, Feleszko W, Gomez Casado C, Hoffmann-Sommergruber K, Janda J, Jiménez-Saiz R, Jutel M, Knol E, Kortekaas Krohn I, Kothari A, Makowska J, Moniuszko M, Morita H, O'Mahony L, Nadeau K, Ozdemir C, Pali-Schöll I, Palomares O, Papaleo F, Prunicki M, Schmidt-Weber CB, Sediva A, Schwarze J, Shamji MH, Tramper-Stranders G, van W, de Veen, Untersmayr E.
Allergy. 2020 Jun 25. doi: 10.1111/all.14462. [Epub ahead of print]. Review.
SARS-COV-2 as possible inducer of viral reactivations.
Ciccarese G, Parodi A, Drago F.
Dermatol Ther. 2020 Jun 19:e13878. doi: 10.1111/dth.13878. [Epub ahead of print] No abstract available. Commentary.
SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection.
Singh Y, Gupta G, Kazmi I, Al-Abbasi FA, Negi P, Chellappan D, Dua K.
Dermatol Ther. 2020 Jun 18:e13871. doi: 10.1111/dth.13871. [Epub ahead of print] No abstract available. Commentary / review.
Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?
Parodi A, Gasparini G, Cozzani E.
J Am Acad Dermatol. 2020 Jun 4. pii: S0190-9622(20)31028-8. doi: 10.1016/j.jaad.2020.06.003. [Epub ahead of print] No abstract available. Commentary.
High expression of ACE2 on the keratinocytes reveals skin as a potential target for SARS-CoV-2.
Xue X, Mi Z, Wang Z, Pang Z, Liu H, Zhang F.
J Invest Dermatol. 2020 May 23. pii: S0022-202X(20)31602-X. doi: 10.1016/j.jid.2020.05.087. [Epub ahead of print] No abstract available. Pathology study.
Coronavirus disease (COVID-19): An updated review based on current knowledge and existing literature for dermatologists.
Kaur I, Sharma A, Jakhar D, Das A, Aradhya SS, Sharma R, Jindal V, Mhatre M.
Dermatol Ther. 2020 May 24. doi: 10.1111/dth.13677. [Epub ahead of print]. Review.
Can COVID 19 virus be transmitted through sex?
Hafi B, Uvais NA, Jafferany M, Afra TP, Muhammed Razmi T.
Dermatol Ther. 2020 May 24. doi: 10.1111/dth.13679. [Epub ahead of print] No abstract available. Commentary.
Can Covid-19 be a sexually transmitted disease? Posterity will judge.
Gaspari V, Lanzoni A, Patrizi A, Orioni G, Viviani F, Bardazzi F.
Dermatol Ther. 2020 May 24:e13676. doi: 10.1111/dth.13676. [Epub ahead of print] No abstract available. Commentary.
COVID-19 and dermatology: A comprehensive guide for dermatologists.
Fahmy DH, El-Amawy HS, El-Samongy MA, Foud AA, Soliman SH, El-Kady A, Farnetani F, Conti A, Zoeir A, Eissa A, Eissa R, Puliatti S, Sighinolfi MC, Rocco B, Pellacani G.
J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16545. [Epub ahead of print]. Review / commentary.
Effects of 5-alpha reductase inhibitors on lung function: a reason for discontinuation during COVID-19 pandemic?
Kroumpouzos G.
Dermatol Ther. 2020 May 7:e13535. doi: 10.1111/dth.13535. [Epub ahead of print] No abstract available. Letter / commentary.
SARS-CoV-2 possible contamination of genital area: implications for sexual and vertical transmission routes.
Delfino M, Guida M, Patrì A, Spirito L, Gallo L, Fabbrocini G.
J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16591. [Epub ahead of print]. Letter / commentary.
Observations about sexual and other routes of SARS-CoV-2 transmission and its prevention.
Tatu AL, Nadasdy T, Nwabudike LC.
Clin Exp Dermatol. 2020 May 5. doi: 10.1111/ced.14274. [Epub ahead of print]. Letter.
COVID-19：Should sexual practices be discouraged during the pandemic?
Yin Z.
J Am Acad Dermatol. 2020 Apr 30. pii: S0190-9622(20)30761-1. doi: 10.1016/j.jaad.2020.04.140. [Epub ahead of print] No abstract available. Letter.
The Dermatologist's Perspective: Why is COVID-19 mortality lower in females than males?
Murrell DF, Murase JE.
Int J Womens Dermatol. 2020 Apr 30. doi: 10.1016/j.ijwd.2020.04.011. [Epub ahead of print] No abstract available. Review / commentary.
Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?
McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Sinclair R, Müller Ramos P, Washenik K, Andrade M, Herrera S, Goren A.
J Cosmet Dermatol. 2020 Apr 25. doi: 10.1111/jocd.13455. [Epub ahead of print]. Letter.
A preliminary observation: male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity.
Goren A, Vano-Galvan S, Wambier CG, McCoy J, Gomez-Zubiaur A, Moreno-Arrones OM, Shapiro J, Sinclair R, Gold MH, Kovacevic M, Mesinkovska NA, Goldust M, Washeni K.
J Cosmet Dermatol. 2020 Apr 16. doi: 10.1111/jocd.13443. [Epub ahead of print]. Case series.
SARS-COV-2 infection is likely to be androgen mediated.
Wambier CG, Goren A.
J Am Acad Dermatol. 2020 Apr 10. pii: S0190-9622(20)30608-3. doi: 10.1016/j.jaad.2020.04.032. [Epub ahead of print] No abstract available. Commentary.
What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy.
Goren A, Mc Coy J, Wambier CG, Vano-Galvan S, Shapiro J, Dhurat R, Washenik K, Lotti T.
Dermatol Ther. 2020 Apr 1:e13365. doi: 10.1111/dth.13365. [Epub ahead of print] No abstract available. Letter.
Sexual transmission of SARS-CoV-2: a new possible route of infection?
Patrì A, Gallo L, Guarino M, Fabbrocini G.
J Am Acad Dermatol. 2020 Apr 9. pii: S0190-9622(20)30521-1. doi: 10.1016/j.jaad.2020.03.098. [Epub ahead of print] No abstract available. Letter.
Back to CEBD Coronavirus Dermatology Resource Homepage